Favorites and recent references stay on this device. No patient data is stored.
Choose the species
One selection filters the source overview, clinical facts, reports and dose calculator. Literature references are not species-filtered.
Source overview
Recorded excerpts for one species. Each dose remains a separate source entry; no regimen is selected.
Cat · Applies to the overview and full clinical evidence below.
Indications 0
No indications recorded for this species.
Sourced dose regimens 1
180 units/kg (PK target 150 q4h), q4–6h, SC
Pending clinical review (PROPOSED)Not applicable (NOT_APPLICABLE)Source: Plumb's Veterinary Drug Handbook, 7th ed., p. 604–606 (UFH), p. 341–343 (dalteparin), p. 461–463 (enoxaparin) — Dosing table
View source context
Pending clinical review (PROPOSED) Not applicable (NOT_APPLICABLE)
Not applicable · Rule-based (RULE_BASED)
Original excerpt: 180 units/kg (PK target 150 q4h)
Contraindications 0
No contraindications recorded for this species.
Precautions 0
No precautions recorded for this species.
Monitoring 0
No monitoring recorded for this species.
Clinical evidence
Pending clinical review (PROPOSED)Rule-based (RULE_BASED)— applies to the facts and dose entries in this species selection; individual source records retain their own status.
Dose regimens1
This calculator performs arithmetic only on the sourced dosing field shown for each result — it does not verify the field's accuracy, does not select which field to use for a patient, and does not replace a veterinarian's order. Not for clinical use. Confirm every result against the primary source before dispensing.
Dose calculation
Species: Cat. Results use the source regimens shown below.
- Review the source route shown below.
- Enter patient weight and its unit.
- For volume, optionally enter a matching label concentration.
Source route: Subcutaneous (SC)
Manual verification required — this source did not state a per-weight dose this calculator can compute from.
- Source regimen: **180 units/kg (PK target 150 q4h)**, **q4–6h**, SC
- Source formulation
- Not specified in this source
- Dose basis
- Not specified in this source
Indication: Not specified in this source field
Manual verification required — this source did not state a per-weight dose this calculator can compute from.
Plumb's Veterinary Drug Handbook, 7th ed., p. 604–606 (UFH), p. 341–343 (dalteparin), p. 461–463 (enoxaparin) — Dosing table
Adverse effects9
These are counts of spontaneously reported events, not proven adverse effects, causal relationships, or incidence rates.
Bars compare report counts within each species; they do not show incidence.
More reportsFewer reportsCat
- Agitation1 reports
- Anorexia1 reports
- Azotaemia1 reports
- Constipation1 reports
- Death1 reports
- Death by euthanasia1 reports
- Lack of efficacy - NOS1 reports
- Neurological signs NOS1 reports
- Vomiting1 reports
Literature references19
References are linked to this drug. Species applicability is not recorded here, so the species filter does not narrow this list. Imported dates do not retain their original precision; confirm dates in the original citation.
- Apixaban Versus Low-Molecular-Weight Heparin for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis.
Study summary not available in the imported record. Open the original citation to review the study.
- A Multicenter Prospective Cohort Study on the Use of Weight-Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer-Associated Venous Thromboembolism-The WAVe Study.
Study summary not available in the imported record. Open the original citation to review the study.
- Real-world evaluation of therapeutic anticoagulation for cancer-associated thromboembolism: A retrospective analysis.
Study summary not available in the imported record. Open the original citation to review the study.
- Abelacimab in Cancer-Associated Thrombosis: The Right Drug at the Right Time for the Right Purpose. A Comprehensive Review.
Study summary not available in the imported record. Open the original citation to review the study.
- Impact of mild thrombocytopenia on bleeding and recurrent thrombosis in cancer.
Study summary not available in the imported record. Open the original citation to review the study.
Sources: PubMed, National Library of Medicine; openFDA, U.S. Food and Drug Administration; Plumb DC. Plumb's Veterinary Drug Handbook. 7th ed. PharmaVet Inc; 2011.